3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Ovarian Neoplasms
2
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Interventions
lentiviral minigene vaccine of COVID-19 coronavirus
1
cediranib
1
brostallicin
1
Temozolomide
1
Radiation Dose Hypofractionation
1
Doxorubicin
1
Diathermy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Sarcoma, Alveolar Soft Part
×
cediranib
×
Clear all
NCT01337401
2019-01-24
CASPS
Institute of Cancer Research, United Kingdom
Phase 2
Unknown
36 enrolled